• Protein Expression Kit Speeds Time-to-Market for Biotherapeutics

Laboratory Products

Protein Expression Kit Speeds Time-to-Market for Biotherapeutics

Aug 27 2009

Invitrogen launched the GIBCO® OptiCHO™ Protein Express Kit, a new integrated solution for simple and efficient serum-free development of stable cell lines for biotherapeutic development. This
is the first kit of its kind to provide cells banked under cGMP conditions, allowing biotherapeutics manufacturers to speed regulatory submissions and time-to-market. The GIBCO OptiCHO Protein Express Kit incorporates all of the reagents, protocols and documentation required to go from gene to stable cell clones expressing the protein of interest, using a completely serum-free process. All of the products in the workflow are animal-origin free, supporting biomanufacturers to enhance the safety of human therapeutics. The kit is available for research use, however, laboratories interested in pursuing regulatory filings and require a documentation package, can obtain a commercial use license for a one-time fee, with no maintenance costs or royalties.

The OptiCHO Protein Expression Kit can be used as part of a complete workflow for stable cell line development that can be enhanced with the Countess™ Automated Cell Counter to simplify the cell counting steps of the protocol. Optimised components in the kit, such as TOPO® TA Cloning® Kits allow faster, more efficient creation of vectors, and FreeStyle™ MAX Transfection Reagent provide highly efficient, animal origin-free lipid transfection.

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events